Molbio Diagnostics IPO Allotment Status: Check Online on Registrar & NSE,BSE
Add Preferred News Source
As on 12 August 2026, 05:00 PM IST, the allotment for the Molbio Diagnostics IPO of ₹940 crores is expected to be finalized on 13 August 2026. Investors can check the allotment status through Kfin Technologies Ltd. or on the NSE,BSE website using their PAN number or application number.
The subscription for the Molbio Diagnostics IPO closed on 12 August 2026. The IPO was open for bidding from 10 August 2026 to 12 August 2026 and was priced in the range of ₹768 to ₹807 per share. The total issue size was ₹940.
Shares are expected to be credited to investors’ demat accounts on 14 August 2026, while the IPO is scheduled to list on NSE,BSE on 17 August 2026.
How to check Molbio Diagnostics IPO Allotment Status on Registrar site
Step 1: Visit Kfin Technologies Ltd.
Step 2: Select MOLBIO from the drop-down menu on the page
Step 3: Enter details required like PAN Card, Application Number, or Demat Account Number
Step 4: Click on the ‘Submit’ Button and view your allotment status
How to check Molbio Diagnostics IPO Allotment Status on NSE website
Step 1: Go to Status of Issue Application Page on NSE Website
Step 2: Select “Equity & SME IPO bid details”
Step 3: Select IPO Company Code MOLBIO from the Dropdown
Step 4: Enter your PAN & Application Number in the required field
Step 5: Click on “Submit” Button and view your allotment status
How to check Molbio Diagnostics IPO Allotment Status on BSE website
Step 1: Go to Status of Issue Application Page on BSE website
Step 2: Select “Equity” as issue Type
Step 3: Select MOLBIO from the Dropdown
Step 4: Enter your Application Number or PAN Number
Step 5: Enter Captcha
Step 6: Click on “Submit” Button and view your allotment status
Bidding Details for Molbio Diagnostics
QIB Shares Offered | 58,12,863 (49.91%) | [-] |
– Anchor Investor Shares Offered | 34,87,717 (29.95%) | 34,87,717 |
– QIB (Ex. Anchor) Shares Offered | 23,25,146 (19.96%) | 43,33,82,148 |
NII (HNI) Shares Offered | 17,43,859 (14.97%) | 8,68,40,604 |
– bNII > ₹10L | 11,62,573 (9.98%) | 5,90,76,594 |
– sNII < ₹10L | 5,81,286 (4.99%) | 2,77,64,010 |
Retail | 40,69,004 (34.94%) | 5,27,70,906 |
Employee | 20,520 (0.18%) | 2,72,466 |
Total Shares Offered | 1,16,46,246 (100%) | 57,32,66,124 |
Molbio Diagnostics IPO Subscription Status
(As on 12 August 2026, 05:00 PM IST)
Day 1 | 0.82 | 1 | 0.75 | 0.72 | 2.11 |
Day 2 | 3.06 | 1.39 | 3.14 | 5.09 | 4.74 |
Day 3 | 69.96 | 186.39 | 12.4 | 49.71 | 12.82 |
Molbio Diagnostics IPO Subscription Rate
Non-Institutional (HNI) | 49.71 |
Qualified Institutions | 186.39 |
Retail | 12.4 |
Employee | 12.82 |
Total Subscription | 69.96 |
What happens if you get the Molbio Diagnostics IPO allotment?
If you get Molbio Diagnostics IPO allotment, the company’s shares will be credited to your demat account on 14 August 2026, based on your allotment. Once the shares are credited, the amount blocked in your bank account will be debited accordingly.
After the IPO is listed on 17 August 2026 on the NSE,BSE, you may choose to either hold the shares as a long-term investment or sell them in the market.
What if you didn’t get the Molbio Diagnostics IPO allotment?
If you didn’t receive allotment of Molbio Diagnostics IPO:
• Refunds will be initiated on or about 14 August 2026.
• The amount will be credited to your bank account linked to UPI On the other hand, if allotted shares will reflect in your Demat by 14 August 2026
• After the listing date, you can continue to track and invest in the stock directly through Kotak Neo
Molbio Diagnostics IPO Allotment Status FAQs:
The allotment date of the Molbio Diagnostics IPO is 13 August 2026.
You can check the allotment status of the Molbio Diagnostics IPO on the IPO allotment page of the Kfin Technologies Ltd. or the NSE,BSE by entering your PAN number, application number, or Demat account details.
The Molbio Diagnostics IPO refund date is 14 August 2026.
The official Registrar of Molbio Diagnostics IPO is Kfin Technologies Ltd. .
The shares of Molbio Diagnostics are expected to be listed on NSE,BSE on 17 August 2026. You can track listing gains or losses on Kotak Neo.
Buying Molbio Diagnostics on the listing day depends on the company’s valuation, market sentiment, and your investment goals. Always analyse the stock fundamentals and listing price before making any investment decision.
This article is for informational purposes only and should not be considered investment advice from Kotak Neo. For compliance T&C and disclaimers, Visit https://www.kotakneo.com/disclaimer/
Kotak News Desk brings you latest updates, expert insights, and market-ready ideas - helping you stay informed and invest smarter.
Connect on: Linkedin
